
    
      In a large Dutch SCN5A founder population with malignant ventricular arrhythmias, the
      investigators aim to identify genetic modifiers by means of whole-exome sequencing and to
      establish a comprehensive genotype-phenotype correlation, focussing on clinical and cellular
      electrophysiological characteristics and neurocardiac modulation.
    
  